Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 2 |
2019 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Strategies to Address Chimeric Antigen Receptor Tonic Signaling.
Mol Cancer Ther. 2018 Sep;17(9):1795-1815. doi: 10.1158/1535-7163.MCT-17-1097.
Mol Cancer Ther. 2018.
PMID: 30181329
Free PMC article.
Review.
Prospects for combined use of oncolytic viruses and CAR T-cells.
Ajina A, Maher J.
Ajina A, et al.
J Immunother Cancer. 2017 Nov 21;5(1):90. doi: 10.1186/s40425-017-0294-6.
J Immunother Cancer. 2017.
PMID: 29157300
Free PMC article.
Review.
Item in Clipboard
Synergistic combination of oncolytic virotherapy with CAR T-cell therapy.
Ajina A, Maher J.
Ajina A, et al.
Prog Mol Biol Transl Sci. 2019;164:217-292. doi: 10.1016/bs.pmbts.2019.06.015. Epub 2019 Jul 19.
Prog Mol Biol Transl Sci. 2019.
PMID: 31383406
Review.
Item in Clipboard
Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety.
Halim L, Ajina A, Maher J.
Halim L, et al.
Best Pract Res Clin Haematol. 2018 Jun;31(2):117-125. doi: 10.1016/j.beha.2018.04.002. Epub 2018 Apr 21.
Best Pract Res Clin Haematol. 2018.
PMID: 29909912
Review.
Item in Clipboard
An overview of CAR T-cell clinical trial activity to 2021.
Adami A, Maher J.
Adami A, et al.
Immunother Adv. 2021 Mar 9;1(1):ltab004. doi: 10.1093/immadv/ltab004. eCollection 2021 Jan.
Immunother Adv. 2021.
PMID: 34056638
Free PMC article.
Review.
Item in Clipboard
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies.
Mazza R, Maher J.
Mazza R, et al.
Arch Immunol Ther Exp (Warsz). 2021 Dec 12;70(1):2. doi: 10.1007/s00005-021-00640-7.
Arch Immunol Ther Exp (Warsz). 2021.
PMID: 34897554
Free PMC article.
Review.
Item in Clipboard
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation.
Halim L, Das KK, Larcombe-Young D, Ajina A, Candelli A, Benjamin R, Dillon R, Davies DM, Maher J.
Halim L, et al.
Front Immunol. 2022 Feb 9;13:836549. doi: 10.3389/fimmu.2022.836549. eCollection 2022.
Front Immunol. 2022.
PMID: 35222427
Free PMC article.
Item in Clipboard
Cite
Cite